Archrock Vs. Sarepta Therapeutics Industry Stock Comparison

Buy

74

AROC
Archrock

Last Price:

$27.14

Seasonality Move:

4.52%

Buy

57

SRPT
Sarepta Therapeutics

Last Price:

$106.83

Seasonality Move:

8.04%

Buy

74

Archrock (AROC) is a Buy

Is Archrock a Buy, Sell or Hold?

The current Archrock [AROC] share price is $27.12. The Score for AROC is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
AROC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

57

Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

The current Sarepta Therapeutics [SRPT] share price is $106.89. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AROC Stock Price Chart

What is Archrock's stock price today?

The Archrock share price today is $27.12

The current trend is relatively stagnant and AROC is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

The Sarepta Therapeutics share price today is $106.89

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

AROC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.23	Sell
Relative Strength Index (14 RSI):	48.29	Sell
Chaikin Money Flow:	1322144	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(26.98 - 28.96)	Sell
Bollinger Bands (100):	(22.05 - 27.91)	Buy

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.25	Sell
Relative Strength Index (14 RSI):	41.97	Sell
Chaikin Money Flow:	469170	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(106.93 - 115.87)	Sell
Bollinger Bands (100):	(111.92 - 127.28)	Sell

AROC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	27.06	Buy
20-day SMA:	27.79	Sell
50-day SMA:	27.11	Buy
200-day SMA:	22.51	Buy
8-day EMA:	27.03	Buy
20-day EMA:	27.44	Sell
50-day EMA:	26.93	Buy
200-day EMA:	23.06	Buy

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	106.35	Buy
20-day SMA:	109.97	Sell
50-day SMA:	116.57	Sell
200-day SMA:	127.54	Sell
8-day EMA:	106.76	Buy
20-day EMA:	109.7	Sell
50-day EMA:	114.67	Sell
200-day EMA:	122.08	Sell

Archrock Earnings Growth & AROC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.03 per share, an increase this year of $0.34 per share, and an increase next year of $0.12 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings increase this quarter of $2.86 per share, a decrease next quarter of $0.29 per share, an increase this year of $7.95 per share, and an increase next year of $4.16 per share.

Archrock Technical Analysis

	Feb 13	Feb 14	Feb 18	Feb 19	Feb 20	Feb 21	Feb 25	Feb 26	Feb 27	Feb 28
	Feb
	13	14	18	19	20	21	25	26	27	28
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

	Feb 13	Feb 14	Feb 18	Feb 19	Feb 20	Feb 21	Feb 25	Feb 26	Feb 27	Feb 28
	Feb
	13	14	18	19	20	21	25	26	27	28
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):